5.5 Product Recalls, Supply Chain Monitoring, & Device Incident Reporting

CBIC Associate Infection Prevention and Control a-IPC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the CBIC a-IPC Certification 1.2 Exam Format, Scoring, & Logistics 1.3 Effective Study Strategies & Preparation Plan

2 Chapter 2: Processes to Identify Infectious Diseases

2.1 Chain of Infection & Pathogen Characteristics 2.2 Diagnostic & Laboratory Testing in IPC 2.3 Identifying Healthcare-Associated Infection Syndromes 2.4 Specimen Collection, Handling, Storage, & Transport 2.5 Colonization, Infection, Contamination, & Pseudo-Infection 2.6 Prophylactic, Empiric, & Therapeutic Antimicrobial Use 2.7 Host Risk Factors & Emerging Infectious Disease Threats

3 Chapter 3: Surveillance and Epidemiologic Investigation

3.1 Surveillance Methods & Program Design 3.2 Epidemiological Calculations & Rate Metrics 3.3 Outbreak Investigation Protocols & Epidemic Curves 3.4 NHSN Definitions & Standardized Infection Ratios (SIR) 3.5 Descriptive Statistics & Presenting Surveillance Data 3.6 Surveillance Across the Care Continuum 3.7 Notifiable Disease Reporting, Data Sources, & Registries 3.8 Data Validation & Surveillance Program Evaluation 3.9 Outbreak Control Measures, Environmental Sampling, & Reporting

4 Chapter 4: Preventing and Controlling Transmission

4.1 Standard Precautions & Hand Hygiene Guidelines 4.2 Transmission-Based Precautions & Isolation Protocols 4.3 PPE Selection, Donning, Doffing, & Safety 4.4 Safe Injection Practices & Medication Preparation 4.5 Patient-Care Equipment & Point-of-Care Device Handling 4.6 Emergency Preparedness & the Infection Preventionist's Disaster Role 4.7 Bioterrorism, Special Pathogens, & Community Response Planning

5 Chapter 5: Environment of Care

5.1 Environmental Cleaning & Surface Disinfection 5.2 Water Utilities, Air Handling, & Building Systems 5.3 Construction, Renovation, & Infection Control Risk Assessment (ICRA) 5.4 Laundry, Linen, Waste Management, & Food Safety 5.5 Product Recalls, Supply Chain Monitoring, & Device Incident Reporting

6 Chapter 6: Cleaning, Disinfection, and Sterilization of Medical Devices

6.1 Spaulding Classification System 6.2 Reprocessing Steps & High-Level Disinfection (HLD) 6.3 Sterilization Methods, Monitoring, & Quality Assurance 6.4 Single-Use Devices, Outsourced Reprocessing, & IFU Review 6.5 Reprocessing Failure Investigation & Patient Notification

7 Chapter 7: Employee and Occupational Health

7.1 Occupational Exposures & Post-Exposure Prophylaxis 7.2 Healthcare Personnel Immunizations & Screening 7.3 Work Restrictions & Fit-for-Duty Evaluations 7.4 Sharps Injury Prevention, Product Sensitivities, & Alternatives

8 Chapter 8: Management, Communication, and Antimicrobial Stewardship

8.1 IPC Program Governance, Policies, & Accreditation 8.2 Interdisciplinary Collaboration & Crisis Communication 8.3 Antimicrobial Stewardship Principles & Interventions 8.4 Chain of Command, Resource Advocacy, & the Business Case

9 Chapter 9: Education, Research, and Performance Improvement

9.1 Adult Learning Principles & Staff Education 9.2 Quality Improvement Models & Implementation Science 9.3 Critical Appraisal of Infection Prevention Literature

5.5 Product Recalls, Supply Chain Monitoring, & Device Incident Reporting

Key Takeaways Explain This Topic AI

FDA classifies recalls by risk: Class I carries a reasonable probability of serious adverse health consequences or death, Class II involves temporary or reversible harm, and Class III is unlikely to cause adverse consequences.

Under the Medical Device Reporting regulation, user facilities must report device-related deaths to both the FDA and the manufacturer, and serious injuries to the manufacturer, within 10 working days.

The infection preventionist's role in a recall is to determine whether the product was used, identify which patients were exposed, and assess whether patient notification or testing is warranted.

Product substitution during shortages introduces new risk because the replacement may have different instructions for use, different contact times, or incompatible disinfectants.

Heater-cooler units, duodenoscopes, contaminated alcohol prep pads, and compounded sterile products are the reference cases for device and product-related infection outbreaks.

Last updated: August 2026

5.5 Product Recalls, Supply Chain Monitoring, & Device Incident Reporting

Quick Answer: Class I recall = reasonable probability of serious harm or death . Class II = temporary or medically reversible harm. Class III = unlikely to cause harm. Under 21 CFR Part 803 , user facilities report device-related deaths to FDA and the manufacturer and serious injuries to the manufacturer , within 10 working days . The IP determines who was exposed and whether notification and testing are warranted.

The blueprint requires monitoring infection prevention processes related to product recalls covering equipment, food, medications, and supplies. Materials management owns the logistics; infection prevention owns the patient-impact question that logistics cannot answer.

FDA Recall Classification

Class Definition Examples

Class I Reasonable probability that use will cause serious adverse health consequences or death Contaminated alcohol prep pads, non-sterile products labeled sterile, contaminated compounded injectables

Class II May cause temporary or medically reversible adverse consequences; probability of serious harm is remote Packaging defects, labeling errors with modest clinical impact

Class III Unlikely to cause adverse health consequences Minor labeling or cosmetic defects

Related but distinct actions:

Market withdrawal — a minor violation not subject to legal action (e.g., normal stock rotation issues)
Safety alert / Field safety notice — informs users of a risk without removing product
Stock recovery — product retrieved before it left the manufacturer's control
The Recall Response Workflow

Loading diagram...

What the infection preventionist contributes
Determine clinical use — which departments used the product, for what, and over what date range

Identify exposed patients — via lot number tracking, unique device identification (UDI), implant logs, procedure records, and the electronic health record

Assess infection risk — is the hazard microbial contamination, sterility failure, reprocessing failure, or a non-infectious defect? A packaging defect on a noncritical item is not the same problem as a contaminated injectable

Advise on notification and testing — with risk management, legal, executive leadership, and the health department

Enhance surveillance — actively look for infections among exposed patients rather than waiting for them to be reported

Close the loop — verify the product is out of every storage location, including procedure carts, code carts, unit stock, and clinic satellites, which is where recalled product hides

Exam Tip: Do not discard recalled product. Quarantine it, label it, and segregate it. It is required for manufacturer and regulatory investigation, and destroying it eliminates the ability to determine what happened.

Mandatory Device Reporting (21 CFR Part 803)

Hospitals are user facilities under the Medical Device Reporting regulation, with legal obligations distinct from voluntary reporting.

Event Report to Timeframe
Device-related death FDA and the manufacturer 10 working days
Device-related serious injury Manufacturer (to FDA if the manufacturer is unknown) 10 working days
Annual summary of reports submitted FDA By January 1 each year

MedWatch (Form 3500) is the voluntary reporting channel used by healthcare professionals for adverse events and product problems involving drugs, biologics, and devices; Form 3500A is the mandatory form. Voluntary MedWatch reporting is how most emerging device-related infection risks are first detected nationally, so an IP who suspects a device-associated infection pattern should report even when reporting is not compulsory.

Reference Cases Worth Knowing

Event Mechanism Lesson

Contaminated alcohol prep pads ( Bacillus cereus ) Manufacturing contamination of a product presumed sterile Even the simplest supply can be the vehicle

Duodenoscope-associated CRE Elevator channel design defect resisting reprocessing Device design can defeat correct reprocessing

Heater-cooler units ( Mycobacterium chimaera ) Aerosolization from the water tank into the surgical field during cardiothoracic surgery, with incubation of months to years Long latency means look-back windows can span years

Compounded methylprednisolone (2012) Fungal contamination in a compounding pharmacy Compounding outside USP <797> controls is catastrophic

Contaminated ultrasound gel ( Burkholderia , Pseudomonas ) Non-sterile gel used in sterile or percutaneous procedures Match product sterility to procedure invasiveness

Supply Shortages and Substitution

Shortages are chronic, and substitution silently introduces risk. Before a substitute enters use, the infection preventionist should verify:

Question Why it matters
Does the substitute have a different IFU ? Different contact time, dilution, or dwell time

Is it compatible with our devices and surfaces? A bleach-based wipe may destroy equipment validated for quaternary ammonium

Does it carry the same EPA claims ? A product without a C. difficile or C. auris claim cannot replace one that has it

Does it require different PPE or ventilation ? Peracetic acid and glutaraldehyde have occupational exposure limits

Does it need training before use? Unfamiliar product plus no training equals silent non-compliance

Is it the correct sterility level for the procedure? Non-sterile substituted for sterile is a recognized outbreak mechanism

Substitutions should be routed through the value analysis or product standardization committee , with infection prevention as a standing member — the single most effective structural control for this risk. Conservation strategies during shortage should likewise be set by policy, with defined tiers, rather than improvised by individual units.

Tracking and traceability

Unique Device Identification (UDI) captured in the record makes the "who was exposed" question answerable in minutes rather than weeks. Implant logs, lot number capture for injectables, and sterilization load records serve the same purpose. When a facility cannot answer that question, it is forced to notify a much larger population than was actually at risk — which is both harmful to patients and costly.